In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

CRISPR Therapeutics AG. Trade Record

NASDAQ:CRSP CRISPR Therapeutics AG stock gains 21.82% Exit May 31, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart CRSP May 10, 2018, priceSeries
About CRISPR Therapeutics AG

CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The CRISPR/Cas9 technology allows for changes to genomic DNA. The company has strategic collaborations with Bayer AG and Vertex Pharmaceuticals to develop CRISPR-based therapeutics in other diseases. It operates in Switzerland, the United States, and the United Kingdom. CRISPR Therapeutics AG is headquartered in Basel, Switzerland.

Trade Information
Trade Type
Entry Date
May 10, 2018
Entry Price
Sell Date
May 31, 2018
Sell Price
Net Gain
Hold Time
14 Trading Days